Phenoxybenzamine in Neurogenic Bladder Dysfunction After Spinal Cord Injury. II. Autonomic Dysreflexia
- 1 April 1978
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 119 (4) , 483-484
- https://doi.org/10.1016/s0022-5347(17)57524-2
Abstract
Phenoxybenzamine blockade of the .alpha.-receptor site can abolish the vascular and internal sphincter responses in patients with chronic recurrent autonomic dysreflexia associated with bladder filling or contraction. The life-threatening hypertensive response is suppressed by this medication. Therefore, the drug is a beneficial adjunct in the pharmacologic management of autonomic dysreflexia. When the drug is used patients can be maintained free of a catheter. The drug had no serious side effects at the dose regimen used. One particularly significant advantage is its long duration of action.sbd.patients occasionally can skip doses of medication and not suffer acute symptoms.This publication has 6 references indexed in Scilit:
- Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man.Circulation Research, 1976
- Treatment of Autonomic Dysreflexia with Phenoxybenz AmineJournal of Urology, 1976
- Cardiovascular responses to bladder distension in patients with spinal transectionAmerican Journal of Physiology-Legacy Content, 1975
- Relationship between Serum Dopamine-β-Hydroxylase Activity, Catecholamine Metabolism, and Hemodynamic Changes during Paroxysmal Hypertension in QuadriplegiaCirculation Research, 1974
- Autonomic Hyper-Reflexia — Suppression with Alpha-Adrenergic Blocking AgentsNew England Journal of Medicine, 1970
- AUTONOMIC HYPERREFLEXIA AND ITS CONTROL IN PATIENTS WITH SPINAL CORD LESIONSAnnals of Internal Medicine, 1956